Abstract:Synaptic dysfunction in CNS disorders is the outcome of perturbations in physiological synapse structure and function, and can be either the cause or the consequence in specific pathologies. Accumulating data in the field of neuropsychiatric disorders, including autism spectrum disorders, schizophrenia and bipolar disorder, point to a neurodevelopmental origin of these pathologies. Due to a relatively early onset of behavioural and cognitive symptoms, it is generally acknowledged that mental illness initiates at the synapse level. On the other hand, synaptic dysfunction has been considered as an endpoint incident in neurodegenerative diseases, such as Alzheimer's, Parkinson's and Huntington's, mainly due to the considerably later onset of clinical symptoms and progressive appearance of cognitive deficits. This dichotomy has recently been challenged, particularly since the discovery of cell reprogramming technologies and the generation of induced pluripotent stem cells from patient somatic cells. The creation of ‘disease-in-a-dish’ models for multiple CNS pathologies has revealed unexpected commonalities in the molecular and cellular mechanisms operating in both developmental and degenerative conditions, most of which meet at the synapse level. In this review we discuss synaptic dysfunction in prototype neurodevelopmental and neurodegenerative diseases, emphasizing overlapping features of synaptopathy that have been suggested by studies using induced pluripotent stem-cell-based systems. These valuable disease models have highlighted a potential neurodevelopmental component in classical neurodegenerative diseases that is worth pursuing and investigating further. Moving from demonstration of correlation to understanding mechanistic causality forms the basis for developing novel therapeutics.

Synaptic deficits in iPSC-derived cortical interneurons in schizophrenia are mediated by NLGN2 and rescued by N-acetylcysteine

Dysregulated Protocadherin-Pathway Activity As an Intrinsic Defect in Induced Pluripotent Stem Cell–derived Cortical Interneurons from Subjects with Schizophrenia

Aberrant neuronal connectivity and network activity of neurons derived from patients with idiopathic schizophrenia

GABAergic neuron dysregulation in a human neurodevelopmental model for major psychiatric disorders

Genetic mechanisms for impaired synaptic plasticity in schizophrenia revealed by computational modeling

Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning

Pharmacological intervention in young adolescents rescues synaptic physiology and behavioural deficits in Syngap1+/− mice

Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models

Neuregulin 1 Promotes Excitatory Synapse Development and Function in Gabaergic Interneurons

Activated Microglia Cause Metabolic Disruptions in Developmental Cortical Interneurons That Persist in Interneurons from Individuals with Schizophrenia

Restoring Synaptic Balance in Schizophrenia: Insights from a thalamo-cortical conductance-based model.

Synaptic Protein DLG2 Controls Neurogenic Transcriptional Programs Disrupted in Schizophrenia and Related Disorders

Abnormal Synaptic Plasticity and Impaired Cognition in Schizophrenia

Reduced prefrontal synaptic connectivity and disturbed oscillatory population dynamics in the CNTNAP2 model of autism

Autophagy defects at weaning impair complement-dependent synaptic pruning and induce behavior deficits

A stem cell-based assay platform demonstrates alpha-synuclein dependent synaptic dysfunction in patient-derived cortical neurons

Impaired hippocampal plasticity associated with loss of recycling endosomal SLC9A6/NHE6 is ameliorated by the TrkB agonist 7,8-dihydroxyflavone

The schizophrenia risk gene C4 induces pathological synaptic loss by impairing AMPAR trafficking

Attenuated bidirectional short-term synaptic plasticity in the dentate gyrus of Schnurri-2 knockout mice, a model of schizophrenia

Reduction of SynGAP-γ, disrupted splicing of , and oligodendrocyte deficits in mice, a genetic model of schizophrenia and neurodevelopmental disorder

A concerted neuron–astrocyte program declines in ageing and schizophrenia